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Abstract
Neural stem cells (NSCs) are the progenitors of neurons and glial cells during both embryonic development and adult life.
The unstable regulatory protein Geminin (Gmnn) is thought to maintain neural stem cells in an undifferentiated state while
they proliferate. Geminin inhibits neuronal differentiation in cultured cells by antagonizing interactions between the
chromatin remodeling protein Brg1 and the neural-specific transcription factors Neurogenin and NeuroD. Geminin is widely
expressed in the CNS during throughout embryonic development, and Geminin expression is down-regulated when
neuronal precursor cells undergo terminal differentiation. Over-expression of Geminin in gastrula-stage Xenopus embryos
can expand the size of the neural plate. The role of Geminin in regulating vertebrate neurogenesis in vivo has not been
rigorously examined. To address this question, we created a strain of Nestin-Cre/Gmnn
fl/fl mice in which the Geminin gene
was specifically deleted from NSCs. Interestingly, we found no major defects in the development or function of the central
nervous system. Neural-specific Gmnn
D/D mice are viable and fertile and display no obvious neurological or
neuroanatomical abnormalities. They have normal numbers of BrdU
+ NSCs in the subgranular zone of the dentate gyrus,
and Gmnn
D/D NSCs give rise to normal numbers of mature neurons in pulse-chase experiments. Gmnn
D/D neurosphere cells
differentiate normally into both neurons and glial cells when grown in growth factor-deficient medium. Both the growth
rate and the cell cycle distribution of cultured Gmnn
D/D neurosphere cells are indistinguishable from controls. We conclude
that Geminin is largely dispensable for most of embryonic and adult mammalian neurogenesis.
Citation: Schultz KM, Banisadr G, Lastra RO, McGuire T, Kessler JA, et al. (2011) Geminin-Deficient Neural Stem Cells Exhibit Normal Cell Division and Normal
Neurogenesis. PLoS ONE 6(3): e17736. doi:10.1371/journal.pone.0017736
Editor: Cesario Borlongan, University of South Florida, United States of America
Received November 17, 2010; Accepted February 10, 2011; Published March 9, 2011
Copyright:  2011 Schultz et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by grants to TJM from the American Heart Association (#0630290N, www.aha.org), the Illinois Division of the American
Cancer Society (www.cancer.org), the National Heart Lung and Blood Institute (R21HL093500), and the Schweppe Foundation. The funders had no role in study
design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have read the journal’s policy and have the following conflicts: TJM is an inventor for the patent "Geminin Gene and Protein"
(US Patent #6,548,290) that describes manipulating the Geminin level in cells to treat neurodegenerative diseases. The Assignee for this patent is the President
and Fellows of Harvard University. TJM’s status as an inventor does not alter our adherence to all PLoS guidelines concerning the sharing of data and materials as
outlined in the guidelines for authors.
* E-mail: t-mcgarry@northwestern.edu
. These authors contributed equally to this work.
Introduction
All neurons and glial cells in the brain are derived from neural
stem cells (NSCs). NSCs maintain their own numbers by self-
renewal and also give rise to daughter cells that terminally
differentiate into neurons, astrocytes, and oligodendrocytes [1,2].
NSCs have been found to persist in the adult brain and generate
new neurons throughout adult life, particularly in the subgranular
zone (SGZ) of the dentate gyrus and the subventricular zone (SVZ)
of the lateral ventricles [3]. This raises the exciting possibility that
NSCs may be useful for the therapy of neurodegenerative diseases.
The factors that control the division and differentiation of NSCs
are of tremendous scientific and medical importance.
Geminin (Gmnn) is an unstable regulatory protein that is thought
to maintain neural progenitor cells in an undifferentiated state
while they proliferate [4]. Geminin is expressed in both embryonic
and adult mouse neural progenitor cells, and in the Xenopus
central nervous system throughout embryonic development [5,6].
Geminin is preferentially expressed in neural precursor cells, and
expression is down-regulated before neural differentiation [7] [6].
Geminin binds to Brg1, the catalytic (ATPase) subunit of a SWI/
SNF chromatin remodeling complex, and inhibits its recruitment
to neuron-specific promoters by the basic helix-loop-helix
(bHLH) transcription factors Neurogenin (Ngn) and NeuroD
[7]. A complex between Geminin and the transcription factor
AP4 represses the transcription of neuronal genes in non-
neuronal cell types [8]. In addition to its effects on the nervous
system, Geminin inhibits tissue differentiation in a variety of
other organs by binding and inhibiting various transcription
factors and chromatin remodeling proteins, including sine oculis
(Six) and Homeobox (Hox) transcription factors and the Polycomb
protein Scmh1 [7,9,10].
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the extent of DNA replication to one round per S phase by
binding and inhibiting the essential replication factor Cdt1 [11].
The concentration of Geminin is cell-cycle regulated; the protein
begins to accumulate at the G1/S transition and persists
throughout S and G2 phase. Geminin is destroyed by ubiquitin-
dependent proteolysis during M phase, which allows a new round
of replication in the next cell cycle [12]. This expression pattern
has been documented extensively in developing mouse brains [6].
Six and Hox transcription factors can compete with Cdt1 for
binding to Geminin [9,10], raising the possibility that Geminin
links exit from the cell cycle with cell differentiation. According to
this model, the destruction of Geminin when cells enter G0 phase
would relieve the repression of Brg1 and other transcription
proteins and trigger terminal differentiation [4,13,14].
In early embryos Geminin can also act as an inducer of nervous
tissue. In an unbiased expression-cloning screen, Geminin was
identified as a molecule that expands the size of neural plate in
Xenopus embryos [5]. These effects are correlated with increased
expression of the proneural gene Neurogenin-related 1 (Ngr1) and
decreased expression of BMP4, an epidermis-inducing growth
factor. Over-expression of Geminin in Drosophila embryos
induces ectopic neural cells in the epidermis [15].
The role of Geminin in regulating neural development has been
examined by deleting its gene from model organisms. C. elegans
embryos treated with Geminin siRNA show gonadal abnormalities
and ,20% of the worms are infertile, but no neural phenotype has
been described [16]. Geminin
D/D Drosophila embryos die at larval
stages with mostly normal neuroanatomy, although a small
percentage of them have sharply reduced numbers of peripheral
neurons [15]. Geminin-deficient Xenopus and mouse embryos do
not develop past the blastula stage because of defects in DNA
replication. Geminin-depleted Xenopus embryos arrest cell
division in G2 phase at the mid-blastula stage because over-
replication activates the DNA replication checkpoint [17,18].
Gmnn
D/D mouse embryos arrest development at about the 8-cell
stage, as soon as the maternal supply of Geminin is exhausted
[19,20]. Their cells contain more nuclear DNA than normal,
consistent with over-replication of the DNA. Interestingly, the
Gmnn
D/D cells prematurely differentiate as trophoblast cells and
none express markers of the embryonic stem cells that form the
embryo proper. Gmnn(2) Xenopus and mouse embryos arrest
development long before neural induction takes place, which has
precluded examining the role of Geminin in vertebrate neural
development using a rigorous genetic system.
To address this question, we constructed a strain of mice in
which Geminin was specifically deleted from neural stem cells. To
our surprise, we found that neural-specific Geminin
D/D mice
displayed no obvious neurological defects and had apparently
normal neurogenesis. We conclude that Geminin is dispensable for
normal neurogenesis during most of embryogenesis and in
adulthood.
Results
The mouse genome contains a single copy of the Geminin gene,
which is composed of seven exons. Exons 5, 6, and 7 encode
Geminin’s dimerization domain and the domains that bind Cdt1
and Brg1 (Figure S1). Because these domains are essential for
Geminin’s biological activity [21], deletion of these exons is
predicted to produce a Geminin
null allele. We flanked exons 5, 6,
and 7 with loxP sites to create a floxed Geminin allele (Gmnn
fl) and
established a line of Gmnn
fl/fl mice, which are completely viable
and fertile [22]. To delete Geminin specifically from nerve cells,
Gmnn
fl/fl mice were crossed to Nestin-Cre mice. Nestin is a
neurofilament protein that is expressed in neural precursor cells
and NSCs [23]. Nestin-Cre mediated recombination begins around
embryonic day 7.5 (e7.5), the time when the neural plate first
forms, and continues throughout adulthood. Recombination is
virtually complete in all neurons and glial cells by e15 [24,25].
Nestin-Cre/Gmnn
fl/fl mice were born in the expected Mendelian
ratio (Table 1) and were indistinguishable from their control
littermates in terms of size, activity, and longevity (Figure 1B).
They moved all four extremities and exhibited normal locomotor
activity. Their feeding and avoidance behavior were both normal,
and they responded normally to noxious stimuli. Both males and
females were able to mate and rear pups until the time of weaning,
although the average litter size was slightly reduced when either
parent had the genotype Nestin-Cre/Gmnn
fl/fl or if the male had the
genotype Nestin-Cre/Gmnn
fl/+ (Table 2). The brains of Nestin-Cre/
Gmnn
fl/fl mice were grossly normal in appearance and had no
obvious neuroanatomical defects upon sectioning (Figure 1A and
1C).
To confirm that the Geminin gene had been deleted, we
isolated protein and RNA samples from the brains of e14.5
animals. Geminin protein was undetectable in the brains of Nestin-
Cre/Gmnn
fl/fl mice compared to the brains of littermate controls
(Figure 2A). The brains of e14.5 and e16.5 Nestin-Cre/Gmnn
fl/fl
mice had only ,20% of the level of intact Geminin mRNA found
in littermate controls as judged by quantitative RT-PCR
(Figure 2C). We hypothesized that the residual amount of
Geminin message may have come from Geminin expression in
vascular or other non-neural cell types. To see if this was the case,
we cultured neurospheres from the brains of newborn mice and
measured Geminin mRNA levels in these purified NSC
populations. The level of intact Geminin RNA in Nestin-Cre/
Gem
fl/fl neurospheres was only ,0.2% of the concentration in
control neurospheres, which indicates virtually complete deletion
of the Geminin gene (Figure 2C, bottom panel). As an additional
control we crossed our mice to R26R-LacZ mice, in which a loxP-
flanked transcription/translation STOP cassette is inserted
between the ROSA promoter and the b-galactosidase gene [26].
Cre-mediated recombination removes the STOP cassette and
causes b-galactosidase expression in cells that express Cre and their
descendants. The brains of adult (6–8 week old) Nestin-Cre/Gem
fl/fl/
R26R-LacZ mice showed b-galactosidase expression in virtually all
Table 1. Viability of Nestin-Cre/Gem
fl/fl Mice.
Offspring
Parents Nestin-Cre Gem(+/loxP) Gem(+/loxP) Gem(loxP/loxP) Nestin-Cre Gem(loxP/loxP) P Value (x
2)
Nes-Cre/Gem
+/fl XG e m
fl/fl 22 21 27 28 0.82
Nes-Cre/Gem
fl/fl XG e m
fl/fl -- -- 42 33 0.75
doi:10.1371/journal.pone.0017736.t001
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fl/fl/R26R-LacZ mice
showed no b-galactosidase expression (Figure 2B). Taken together,
our results indicate that deletion of the Geminin gene is mostly
complete by e14.5 and virtually complete by birth, consistent with
what has been previously reported for other mice that express
Nestin-Cre [24,25]. The persistence of b-galactosidase-expressing
neurons in the brains of adult Nestin-Cre/Gmnn
fl/fl/R26R-LacZ mice
excludes the possibility that neurogenesis is rescued by rare cells
that escape Cre-mediated Geminin deletion.
Next we examined the process of neurogenesis in more detail to
see if we could detect quantitative defects in neuron formation. First
we compared the number of NSCs present in the SGZ of the
dentate gyrus of 2-month old Nestin-Cre/Gmnn
fl/fl and control mice.
The mice were injected with bromodeoxyuridine (BrdU) and
24 hours later the brains were fixed, sectioned, and stained with
anti-BrdU antibodies. There was no significant difference in the
number of BrdU
+ NSCs in the dentate gyri of Nestin-Cre/Gmnn
fl/fl
and control mice (Figure 3A and 3B). We also performed a pulse-
chase experiment to monitor the differentiation of NSCs into
neurons. Adult 7 week-old mice were injected daily with BrdU for
12 days, then 9 weeks later their brains were fixed, sectioned, and
stained with antibodies against BrdU and the neuronal marker
NeuN (Figure 3C). We counted the number of newly born neurons
(NeuN
+BrdU
+ cells) in the dentate gyrus using confocal microscopy.
We found no difference in the number of BrdU
+NeuN
+ cells in the
dentate gyri of Nestin-Cre/Gmnn
fl/fl or control mice. These results
indicate that in Nestin-Cre/Gem
fl/fl brains the number of NSCs is
normal and their rate of differentiation into neurons is normal.
Figure 1. Nes-Cre/Gmnn
fl/fl Mice have Normal Neuroanatomy and Normal Survival. (A) Whole-mount brains of Gmnn
fl/fl (left) and Nes-Cre/
Gmnn
fl/fl (right) mice. (B) Survival of Gmnn
fl/fl (black) and Nes-Cre/Gmnn
fl/fl (red) mice. Numbers above the X axis indicate the number of mice that were
at risk at each timepoint (black, control animals; red, Nes-Cre/Gmnn
fl/fl animals). Controls include both Gmnn
fl/fl and Gmnn
fl/+ animals. (C)
Representative Nissl-stained sections of the cortex and the cerebellum of Gmnn
fl/fl and Nes-Cre/Gmnn
fl/fl mice. Scale bar, 2 mm.
doi:10.1371/journal.pone.0017736.g001
Table 2. Fertility of Nestin-Cre/Gmnn
fl/fl Mice.
Genotype Sex Litter size (mean ± SD) # of Litters # of Animals P value
Control M or F 7.862.0 19 6 --
Nes-Cre/Gnmm(fl/+) F 7.461.3 5 3 0.700
Nes-Cre/Gnmm(fl/+) M 5.362.0 9 4 0.007
Nes-Cre/Gnmm(fl/fl) F 5.262.9 15 4 0.002
Nes-Cre/Gnmm(fl/fl) M 5.362.6 19 3 0.006
doi:10.1371/journal.pone.0017736.t002
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in vitro, we used primary neurosphere cultures from neonatal
Nestin-Cre/Gmnn
fl/fl and control brains. Neurosphere cultures could
easily be established from both genotypes. To induce differenti-
ation, neurospheres were cultured in a low concentration of
growth factors then stained with specific antibodies to identify
differentiated neurons (TuJ1
+ cells) or astrocytes (GFAP
+ cells). We
found that Nestin-Cre/Gmnn
fl/fl and control neurospheres produced
equal numbers of GFAP
+ and TuJ1
+ cells (Figure 4).
Finally, we examined the effect of Geminin deletion on the cell
cycle in neurospheres. Both Nestin-Cre/Gmnn
fl/fl and control
neurospheres cells grew at identical rates (Figure 5A), and the
distribution of cells in different phases of the cell cycle was
indistinguishable between the two types of cells (Figure 5B). In
particular, the percentage of Nestin-Cre/Gmnn
fl/fl cells that had
excessive DNA contents .4n was the same as in Gmnn
fl/fl
littermate controls, and both genotypes had the same proportion
of cells with a G2/M DNA content (Figure 5C). These results
indicate that Gmnn
D/D neurosphere cells do not over-replicate their
DNA and display no obvious cell cycle defects.
Discussion
Geminin is widely expressed in the developing brain and is
thought to have two functions in controlling the development of
the central nervous system. Early in development, Geminin acts as
a neural inducer: over-expression of the protein causes expansion
of the neural plate at the expense of the epidermis [5]. Later in
development, Geminin inhibits neuronal differentiation by
inhibiting the recruitment of a SWI/SNF chromatin-remodeling
complex to neuron-specific promoters [7]. Geminin also limits the
extent of DNA replication during the cell cycle by binding and
inhibiting the essential replication factor Cdt1 [27]. Because of its
effects on both the cell cycle and on gene expression, it has been
proposed that Geminin maintains neural stem cells in an
undifferentiated state while they proliferate [4,13,14].
In this study we rigorously examined the role of Geminin in
vertebrate neurogenesis by constructing a strain of Nestin-Cre/
Gmnn
fl/fl mice in which Geminin was deleted from neural stem
cells early in embryonic development. To our surprise, we could
detect no defects in neurogenesis in Geminin
D/D brains. Nestin-Cre/
Gmnn
fl/fl mice had normal viability and displayed no obvious
neurological or neuroanatomical abnormalities. Quantitative
assays of neural stem cell division and differentiation patterns also
revealed no abnormalities. Previous studies have shown that mice
with defects in adult neurogenesis have well defined and
unmistakable phenotypes. For example, mice that carry a NSC-
specific deletion of the chromatin remodeling factor Mll1 develop
growth retardation and ataxia during the second week of life and
die around 4 weeks of age [28]. Mice with a postnatal deletion of
both Numb and Numb-like show defects in lateral ventricle integrity
and SVZ neuroblast survival [29]. We conclude that Geminin is
largely dispensable for adult neurogenesis and for embryonic
neurogenesis after e14.5. Our results are consistent with what has
Figure 2. Geminin is Deleted from the Brains of Nes-Cre/Gmnn
fl/fl Mice. (A) Immunoblot showing the amount of Geminin protein in e14.5
mouse brain homogenates. (B) Xgal staining of coronal brain sections showing b-galactosidase activity in the brains of Nes-Cre/Gmnn
fl/fl/R26R-LacZ
and Gmnn
fl/fl/R26R-LacZ mice. Scale bar, 0.25 mm. (C) Quantitative real-time PCR showing the amount of Geminin mRNA in the brains of e14.5 and
e16.5 mice and in neurospheres cultured from newborn (P0) mice.
doi:10.1371/journal.pone.0017736.g002
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fl/fl Mice. (A) Adult mice were injected with BrdU 24 hours before sacrifice.
Adjacent sections of the hippocampus were stained with either anti-BrdU antibodies or with DAPI. Scale bar, 50 mM. (B) Quantification of the number
of BrdU(+) cells in the subgranular zone of the hippocampus in Nes-Cre/Gmnn
fl/fl mice and control littermates. n=4 for controls; n=3 for Nes-Cre/
Gmnn
fl/fl mice. (C) 7 week-old mice were injected with BrdU for 12 days then sacrificed 9 weeks later. Sections of the hippocampus were stained with
anti-BrdU antibodies and with anti-NeuN antibodies. The Z-stack image on the right shows BrdU
+, NeuN
+, and BrdU
+NeuN
+ cells. Scale bar, 50 mM.
(D)Quantification of the number of BrdU(+)NeuN(+) cells in the hippocampus of Nes-Cre/Gmnn
fl/fl mice and control littermates. n=2 for both
genotypes.
doi:10.1371/journal.pone.0017736.g003
Figure 4. Normal Differentiation of Nes-Cre/Gmnn
fl/fl Neurosphere Cells. (A)Representative images of TuJ1(+) neurons and GFAP(+) astrocytes
derived from Nes-Cre/Gmnn
fl/fl and control neurosphere cells. Scale bar, 50 mM. (B)Quantification of the number of TuJ1(+) neurons and GFAP(+)
astrocytes derived from Nes-Cre/Gmnn
fl/fl and control neurosphere cells. HPF, High Powered Field.
doi:10.1371/journal.pone.0017736.g004
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D/D Drosophila larvae, most of which
have normal neural architecture [15].
It is unlikely that the mouse genome encodes a protein that can
substitute for Geminin, which is a single copy gene. The 41 kD
GEMC1 protein (GEMinin Coiled-coil domain containing protein
1) includes a 49 amino-acid sequence that is ,30% identical to
Geminin’s coiled coil, but GEMC1 serves a different function than
Geminin and is actually required for DNA replication [30]. Mice
carrying a homozygous deletion of the Geminin gene die at the
early blastula stage, as soon as the maternal supply of Geminin is
exhausted [19,20]. We have also observed strong phenotypes
when Geminin is deleted from other types of cells using other types
of Cre drivers. For example, deleting Geminin profoundly affects
the differentiation pattern of bone marrow cells; the production of
red blood cells is virtually abolished while the production of
megakaryocytes is greatly expanded [22].
Geminin’s role in controlling the extent of DNA replication has
been well documented by many different laboratories using many
different experimental systems [11,27]. It is therefore somewhat
surprising that DNA replication and cell division appear
completely normal in Gmnn
D/D neurosphere cells. These cells
probably cycle normally in the absence of Geminin because of
redundant Geminin-independent mechanisms that limit the extent
of DNA replication. For example, in addition to being inhibited by
Geminin, Cdt1 is also destroyed by ubiquitin-dependent proteol-
ysis during S phase, and the degradation is coupled to the
initiation of DNA replication[31]. In order to induce over-
replication in Xenopus egg extracts, it is necessary to both remove
Geminin and inhibit the proteolysis of Cdt1 [17,31,32]. The
requirement for Geminin to prevent re-replication seems to vary
depending upon the type of cell and upon conditions. For
example, Gmnn
D/D white blood cells over-replicate their DNA
when stimulated with growth factors [22], and Gmnn
D/D T
lymphocytes show cell cycle defects when stimulated to proliferate
in vitro [33].
Some of the previous studies that implicated Geminin in
neurogenesis were based on over-expressing the protein, which
may cause non-physiological effects [5,15]. Others employed
cultured cell lines, which may not reproduce all the characteristics
of in vivo NSCs [7]. Some of the previously observed effects on
neurogenesis may have been caused by cell cycle abnormalities
rather than a specific effect of Geminin on neural differentiation.
It remains possible that Geminin is required for very early
neural induction. The neural plate becomes visible as distinct
anatomical structure at e7.5 and the neural tube becomes
completely closed by e10 [34]. Both these events occur several
days before Nestin-Cre mediated recombination is complete. Even
so, Nestin-Cre-mediated recombination has been detected as early
as e7.5, and extensive recombination has occurred in the midbrain
and hindbrain by e9.5 [24,25]. Our targeting construct did not
delete the sequences encoding the small ‘‘neuralizing domain’’
found near Geminin’s amino terminus. Expression of this
fragment in Xenopus embryos induces neural tissue as efficiently
as full-length Geminin [5]. Although we could detect transcripts
encoding this domain in Nestin-Cre/Gmnn
D/D neurospheres, we
could not detect a new fusion protein in Gmnn
D/D brains (Figs. S2
and S3). Geminin deficiency might cause defective neurogenesis in
strains with a different genetic background. It is also possible that
Nestin-Cre/Gem
fl/fl mice will prove to have a subtle neurological or
neuroanatomical defect than could not be detected by the methods
employed here. Such a defect might explain the mild decrease in
fertility we observed in Nestin-Cre/Gmnn
fl/fl mice. Nevertheless, our
results clearly indicate that Geminin is largely dispensable for
mammalian neurogenesis.
Materials and Methods
Ethics Statement
All animal work was performed according to the protocol
approved by the Nothwestern University Animal Care and Use
Committee (Protocol # 2009-0911).
Mouse Breeding
The construction of the Gmnn
fl allele was described previously
[22]. Nestin-Cre mice (B6.Cg-Tg(Nes-Cre)1Kln/J, Jackson Labs
Strain 3771) were kindly provided by Dr. Anjen Chenn
Figure 5. Nes-Cre/Gmnn
fl/fl Neurosphere Cells Show Normal DNA Replication and Normal Cell Cycle Kinetics. (A)Doubling time, (B) cell
cycle phase distribution, and (C) DNA content of neurosphere cells derived from Nes-Cre/Gmnn
fl/fl mice and control littermates.
doi:10.1371/journal.pone.0017736.g005
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fl/fl
mice were mated to Gmnn
fl/fl mice to produce experimental Nes-
Cre/Gmnn
fl/fl mice and control Gmnn
fl/fl littermates. To obtain
embryos at defined embryonic stages, timed matings were
performed in which male and female mice were caged together
overnight then separated immediately after the mating plug
appeared. Genotypes were determined by PCR of tail DNA. The
following primers were used for amplification: Nes-Cre forward
(59-gcctgcattaccggtcgatgcaacga-39), Nes-Cre reverse (59-gtggca-
gatggcgcggcaacaccatt-39), Geminin forward (59-gctcagaggttt-
caggg-39), Geminin
WT reverse (59-catcaggtgttctctcaagtgtctg-39),
and Geminin
fl reverse (59-gctacttccatttgtcacgtcc-39).
Antibodies
Affinity-purified anti-mouse Geminin antibody was obtained by
immunizing rabbits with recombinant his-Geminin and purifying
antibodies from serum over a column of recombinant his-Geminin
coupled to cyanogen bromide sepharose beads [22,35].
Real Time PCR
RNA was isolated from fresh tissue using Trizol reagent
(Invitrogen). cDNA synthesis was carried using a standard kit
(Ambion) and RT-PCR was performed using an Applied
Biosystems 7500 Fast Real Time PCR System. Primers and
fluorescently labeled probes for RT-PCR were designed using
Primer Design software (Applied Biosystems). All RNA levels were
normalized to the amount of 18S ribosomal RNA in each sample.
For Figure 2, Geminin RNA primer sequences were 59-
acggatgctaggccgtgtac-39 (forward), 59-gcaccgtgtagttagtttaccaagag-
39 (reverse), and 59-acgcactgccagcgttgccc-39 (probe). 18S RNA
primer sequences were 59-aacgagactctggcatgctaact-39 (forward),
59-cgccacttgtccctctaagaa-39 (reverse), and 59-ttacgcgacccccgagcgg-
39 (probe). For PCR of exons 3 and 4 (Figure S3), Geminin
primers were 59-gtgaagaatagtcctgtccc-39 (forward) and 59-cca-
cagcttgaagtctgag-39 (reverse). SYBR green was used instead of a
probe.
Histology and Immunohistochemistry
For pulse labeling, mice were injected intra-peritoneally with
three doses of bromodeoxyuridine (Invitrogen B23151, 10 mg/ml
in PBS, 50 mg/kg) separated by two hours. Brains were fixed
24 hours after the last BrdU dose by transcardial perfusion with a
solution of 4% paraformaldehyde in PBS then post-fixed overnight
at 4uC in the same solution. For pulse-chase analysis, mice
received a single daily dose of BrdU (50 mg/kg) for 12 days and
the brains were fixed 9 weeks after the final dose. Free-floating
coronal sections (40 mM) were cut using a vibratome (Leica VT
1000S) and collected in cold PBS. For b-galactosidase staining,
sections were incubated at room temperature in PBS containing
5m MK 3Fe(CN)6, 5 mM K4Fe(CN)6, 2 mM MgCl2, and 1 mg/
ml X-gal (5-bromo-4-chloro-3-indolyl-b-D-galactopyranoside,
Roche). For Nissl staining, paraformaldehyde-fixed brains were
embedded in OCT Medium and cut into frozen sections (10 mM).
Nissl staining was performed using standard procedures [36]. To
stain for BrdU, sections were incubated in 0.1 N HCl in PBS at
60uC for 20 minutes then washed three times in PBS at room
temperature. Sections were blocked in 1X PBS, 10% Normal
Donkey Serum (NDS, Jackson Immuno Research), 0.5% Triton
X-100 (TX-100) and stained overnight at 4uC with anti-BrdU
antibody (Fitzgerald Industries #20-BS17) diluted 1:500 in 1X
PBS, 7.5% NDS, and 0.25% TX-100. After extensive washing in
PBS, sections were sequentially stained with biotinylated Donkey
anti-Sheep antibody (Jackson #713-065-003) diluted in 1X PBS,
5% NDS, and 0.25% TX-100 and with Alexa 663-conjugated
streptavidin (Invitrogen S-21375) diluted in 1X PBS. For NeuN
staining, BrdU-stained sections were blocked in 1X PBS, 4%
Normal Goat Serum (NGS, Jackson), and 0.25% TX-100 then
stained overnight at 4uC with anti-NeuN antibody (Millipore clone
A60, #MAB377) diluted 1:300 in 1X PBS, 2% NGS, and 0.25%
TX-100. After washing in PBS, the sections were stained with
Alexa 488-conjugated Donkey anti-Mouse IgG1 (Invitrogen
A21121) diluted 1:300 in 1X PBS, 1% NDS, and 0.25% TX-
100. Sections were mounted in Vectashield medium containing
DAPI (Vector Laboratories). To determine the number of BrdU
+
cells in the dentate gyrus, we counted every sixth section (8 sections
per brain) and multiplied the result by 6. A total of 900 -1400
BrdU
+ cells were counted per brain. To determine the number of
NeuN
+BrdU
+ double-positive cells, we took confocal images of
representative sections and used Z-stack images to determine the
percentage of BrdU
+ cells that were also NeuN
+, then multiplied
this percentage (,50% for all mice) by the total number of BrdU
+
cells. To determine these percentages we counting an average of
250 BrdU
+ cells per brain.
Neurosphere Culture and Differentiation
Primary neurosphere cultures were obtained from newborn (P0)
mice as described [37,38,39]. Neurospheres were grown in
DMEM/F-12 medium containing N2 supplement, B27 supple-
ment, penicillin, streptomycin, glutamine (all from Invitrogen), and
20 ng/ml Epidermal Growth Factor (EGF, BD Biosciences). After
3 days the cells were dissociated with trypsin, triturated, counted,
and re-seeded at a density of 5 X 10
4 cells/ml. To calculate the
doubling time, cells were trypsinized and re-counted three days
later. For cell cycle analysis the cells were stained with propidium
iodide using standard procedures[40]. To induce differentiation,
dissociated neurosphere cells were seeded onto poly-D-lysine
coated coverslips (Sigma, 20 mg/ml for .1 hour) in medium
containing 1 ng/ml EGF. The medium was changed after 3 days,
and after 7 days the coverslips were washed with PBS and fixed in
1X PBS/4% paraformaldehyde. For antibody staining, coverslips
were washed with 1X PBS/0.1% TX-100 (PBST) then incubated
overnight at 4uC in PBS/5% NGS containing either anti-TuJ1
antibody (Mouse IgG2b, clone SDL.3D10, Sigma #T8660) or
anti-GFAP antibody (Mouse IgG1, clone GA5, Sigma # G3893).
The secondary antibodies were Alexa 488-conjugated goat anti-
mouse IgG2b (Invitrogen # A21141) and Cy3-conjugated goat
anti-rabbit IgG (Jackson Immuno Research #111-165-144)
respectively.
Supporting Information
Figure S1 Protein Domains Deleted in Gmnn
D/D Mice.
(Top) Map of the Geminin locus with color-coded exons. Deleted
exons are enclosed by the rectangle. (Bottom) Exon boundaries
mapped onto the domains of the Geminin protein. D-box,
destruction box; NLS, bipartite Nuclear Localization Signal;
Neural, neuralizing domain (underlined) which overlaps the D-box
and the NLS.
(TIF)
Figure S2 Geminin Deletion does not Generate a
Detectable New Fusion Protein. The full immunoblot from
Figure 2A. Biotinylated MW markers are shown on the left.
(TIF)
Figure S3 Geminin Deletion does not Cause Over-
Expression of Geminin RNA. RNA was isolated from
undifferentiated or differentiated neurospheres from control or
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RNA was determined by RT-PCR. The location of the amplified
fragment is indicated in Figure S1.
(TIF)
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